GrantPostedDiscretionary

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (Clinical Trials Optional)

National Institutes of Health
PAR-26-128
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding

Grant Opportunity Analysis

The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science," which allows eligible organizations to develop unique capabilities and resources to address critical gaps in clinical and translational science. The program specifically targets Clinical and Translational Science Award (CTSA) Program Hubs, permitting active UM1 hub institutions to submit up to two applications for Specialized Innovation Programs (SIPs) per cycle, contingent upon having an awarded UM1 application. This funding is crucial for enhancing research platforms and capabilities that can be disseminated to other CTSA hubs, with applications due by September 28, 2026, and an estimated award date of July 15, 2027. For further inquiries, interested applicants can contact the CTSA Program Branch at NIH via email at RC2NOFO@nih.gov or by phone at 301-827-2017.

Eligible Applicants

Others
Additional Eligibility Information

All applicant organizations and/or active award recipients for PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional) are eligible to apply for Specialized Innovation Programs (SIPs) under this NOFO. Only the primary UM1 CTSA program hub organization is eligible to apply (not partner or collaborator institutions).Companion optional applications may be submitted under the following scenarios:-concurrently with the UM1-while the UM1 application is under review consideration-after the UM1 application is funded-while the UM1 is under consideration for fundingApplications will only be awarded if there is an awarded UM1 application from the applicant organization.Other information on eligibility and number of applications:An active (not in an extension period) UM1 hub institution can submit up to two applications for SIPs per cycle as the primary institution.A CTSA UM1 hub may have up to two SIPs awards as the primary recipient at a given time.No more than two applications may be submitted by a UM1 hub as a primary per application due date and no more than two applications may be awarded to an active (not in an extension period) CTSA UM1 hub as a primary recipient, at a given time.A UM1 hub that is in an extension period is not allowed to submit an application as the primary institution unless a pending UM1 application has been submitted or is under review or funding consideration. Resubmission of a application without the required UM1 application is only allowed if the companion UM1 application is awarded.For the purpose of this NOFO, SIPs awarded in an extension period count towards the maximum of two SIP awards that may be awarded to an active UM1 hub as a primary, at a given time.

Grant Documents

0 Files
No grant documents

No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedMar 9, 2026

Funding Details

No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Grant

Grantor Contact

Name
CTSA Program Branch, Division of Clinical Innovation

CFDA Numbers

93.350

Official Sources